Overall survival of Black patients with newly diagnosed multiple myeloma in the era of triplet and quadruplet therapies

• by Hamlet Gasoyan, Shahzad Raza, Michael B. Rothberg, Jeffrey D. Kovach, Nicholas J. Casacchia, Jason Valent, Faiz Anwer

• October 7, 2026

Aptamer Tests Face the Validation Challenge

Clinical adoption will require reproducibility, quality control, and evidence of diagnostic utility

• October 6, 2026

• 3 min

Bridging the PSMA PET/CT access gap in prostate cancer: evidence, barriers, and priorities for implementation

• by J. Gómez Rivas, L. Fernández Hernández, L. Turpin, A. Peyrottes, M. Rouprêt

• September 29, 2026

Error in Figure 1

• October 5, 2026